Leukemia Acalabrutinib vs Investigator's Choice in Relapsed/Refractory CLL: ASCEND Trial Mar 30, 2023
Leukemia Evaluating Idasanutlin in Relapsed or Refractory AML: The MIRROS Clinical Trial Mar 30, 2023
Leukemia Sequoia: A Comparison of Zanubrutinib vs. Bendamustine Plus Rituximab for CLL/SLL Mar 30, 2023
Head & Neck Cancer KEYNOTE-040: Clinical Trial of Pembrolizumab for Head and Neck Cancer Mar 30, 2023
Head & Neck Cancer Analyzing the Effects of GC4419 on Radiation-Induced Oral Mucositis (OM) Mar 30, 2023
Lung Cancer ADRIATIC Phase 3 Study: Combination Therapy with Durvalumab & Tremelimumab in SCLC Mar 30, 2023
